CANIGEN DHPPI LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR DOGS
CANIGEN DHPPI LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR DOGS
Ovlašten
- Canine parvovirus, strain Cornell 780916, Live
- Canine distemper virus, strain Lederle, Live
- Canine adenovirus 2, strain Manhattan, Live
- Water for injection
- Canine parainfluenza virus, strain Manhattan, Live
Identifikacija proizvoda
Naziv VMP-a:
CANIGEN DHPPI LYOPHILISATE AND SOLVENT FOR SUSPENSION FOR INJECTION FOR DOGS
Canigen DHPPi vakcina A.U.V.
Način primjene:
-
Supkutano
Pojedinosti o proizvodu
Djelatna tvar i jačina:
-
Dostupno samo u English100000.00tissue culture infective dose 501.00unit(s)
-
Dostupno samo u English1000.00tissue culture infective dose 501.00unit(s)
-
Dostupno samo u English10000.00tissue culture infective dose 501.00unit(s)
-
Dostupno samo u English1.00mililitar1.00unit(s)
-
Dostupno samo u English100000.00tissue culture infective dose 501.00unit(s)
Farmaceutski oblik:
-
Liofilizat i otapalo za suspenziju za injekciju
Withdrawal period by route of administration:
-
Supkutano
- Dog
Kod anatomsko-terapijsko-kemijske klasifikacije (ATKvet kȏd):
- QI07AD04
Status odobrenja:
-
Važeće
Dodatne informacije
Entitlement type:
-
Marketing Authorisation
Nositelj odobrenja za stavljanje u promet:
- Virbac
Marketing authorisation date:
Mjesta proizvodnje za izdavanje serije:
- Virbac
Odgovorno tijelo:
- National Food Chain Safety Office
Broj autorizacije:
- 3793/X/16 NÉBIH ÁTI
Datum promjene statusa odobrenja:
Broj postupka:
- FR/V/0297/001
Dotična država članica:
-
Hrvatska
-
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Koliko je bila korisna ova stranica?: